SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-18-009974
Filing Date
2018-07-13
Accepted
2018-07-13 16:16:56
Documents
92
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm 10-Q/A 1512812
2 ex31-1.htm EX-31.1 18022
3 ex31-2.htm EX-31.2 18066
4 ex32-1.htm EX-32.1 7304
5 ex32-2.htm EX-32.2 7362
  Complete submission text file 0001493152-18-009974.txt   5859436

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aker-20170630.xml EX-101.INS 918172
7 XBRL SCHEMA FILE aker-20170630.xsd EX-101.SCH 68615
8 XBRL CALCULATION FILE aker-20170630_cal.xml EX-101.CAL 68723
9 XBRL DEFINITION FILE aker-20170630_def.xml EX-101.DEF 254388
10 XBRL LABEL FILE aker-20170630_lab.xml EX-101.LAB 428008
11 XBRL PRESENTATION FILE aker-20170630_pre.xml EX-101.PRE 368339
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36268 | Film No.: 18952680
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1